Pharmacogenetics in the management of coumarin anticoagulant therapy: The way forward or an expensive diversion?

被引：17
作者：
Greaves, M
机构：
来源：
PLOS MEDICINE | 2005年 / 2卷 / 10期
关键词：
D O I：
10.1371/journal.pmed.0020342
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：944 / 945
页数：2
相关论文
共 11 条
  • [1] D'Ambrosio RL, 2004, HAEMATOLOGICA, V89, P1510
  • [2] The influence of ethnicity on warfarin dosage requirement
    Dang, MTN
    Hambleton, J
    Kayser, SR
    [J]. ANNALS OF PHARMACOTHERAPY, 2005, 39 (06) : 1008 - 1012
  • [3] Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy
    Higashi, MK
    Veenstra, DL
    Kondo, LML
    Wittkowsky, AK
    Srinouanprachanh, SL
    Farin, FM
    Rettie, AE
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (13): : 1690 - 1698
  • [4] Identification of the gene for vitamin K epoxide reductase
    Li, T
    Chang, CY
    Jin, DY
    Lin, PJ
    Khvorova, A
    Stafford, DW
    [J]. NATURE, 2004, 427 (6974) : 541 - 544
  • [5] Vitamin K intake and sensitivity to warfarin in patients consuming regular diets
    Lubetsky, A
    Dekel-Stern, E
    Chetrit, A
    Lubin, F
    Halkin, H
    [J]. THROMBOSIS AND HAEMOSTASIS, 1999, 81 (03) : 396 - 399
  • [6] Bleeding complications of oral anticoagulant treatment: An inception-cohort, prospective collaborative study (ISCOAT)
    Palareti, G
    Leali, N
    Coccheri, S
    Poggi, M
    Manotti, C
    DAngelo, A
    Pengo, V
    Erba, N
    Moia, M
    Ciavarella, N
    Devote, G
    Berrettini, M
    Musolesi, S
    [J]. LANCET, 1996, 348 (9025) : 423 - 428
  • [7] Analysis of risk factors for over-anticoagulation in patients receiving long-term warfarin
    Panneerselvam, S
    Baglin, C
    Lefort, W
    Baglin, T
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1998, 103 (02) : 422 - 424
  • [8] A C1173T dimorphism in the VKORC1 gene determines coumarin Sensitivity and bleeding risk
    Reitsma, PH
    van der Heijden, JF
    Groot, AP
    Rosendaal, FR
    Büller, HR
    [J]. PLOS MEDICINE, 2005, 2 (10) : 996 - 998
  • [9] Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose
    Rieder, MJ
    Reiner, AP
    Gage, BF
    Nickerson, DA
    Eby, CS
    McLeod, HL
    Blough, DK
    Thummel, KE
    Veenstra, DL
    Rettie, AE
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (22) : 2285 - 2293
  • [10] Influence of cytochrome P-450CYP2C9 polymorphisms on warfarin sensitivity and risk of over-anticoagulation in patients on long-term treatment
    Taube, J
    Halsall, D
    Baglin, T
    [J]. BLOOD, 2000, 96 (05) : 1816 - 1819
12